MLND - Millendo -19% with offering said to come at 22.7% discount December, 04 2019 06:57 PM Millendo Therapeutics Millendo Therapeutics (NASDAQ:MLND) is down 18.8% in light postmarket trade after its proposed equity offering is said to amount to $25M in shares.More news on: Millendo Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...